Endo International (ENDP)

Endo International Stock Analysis & Ratings

ENDP Stock Chart & Stats

Day’s Range$0.36 - $1.14
52-Week Range$1.06 - $7.07
Previous Close$1.16
Average Volume (3M)4.89M
Market Cap$142.57M
P/E Ratio-0.4
Next EarningsAug 10, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score1
EPS (TTM)-3.11



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Endo International’s price range in the past 12 months?
Endo International lowest stock price was $1.06 and its highest was $7.07 in the past 12 months.
    What is Endo International’s market cap?
    Endo International’s market cap is $142.57M.
      What is Endo International’s price target?
      The average price target for Endo International is $2.20. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $6.00 ,the lowest forecast is $1.00. The average price target represents 262.80% Increase from the current price of $0.606.
        What do analysts say about Endo International?
        Endo International’s analyst rating consensus is a ‘Moderate Sell. This is based on the ratings of 5 Wall Streets Analysts.
          When is Endo International’s upcoming earnings report date?
          Endo International’s upcoming earnings report date is Aug 10, 2022 which is in 84 days.
            How were Endo International’s earnings last quarter?
            Endo International released its earnings results on May 05, 2022. The company reported $0.66 earnings per share for the quarter, beating the consensus estimate of $0.441 by $0.219.
              Is Endo International overvalued?
              According to Wall Street analysts Endo International’s price is currently Undervalued.
                Does Endo International pay dividends?
                Endo International does not currently pay dividends.
                What is Endo International’s EPS estimate?
                Endo International’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Endo International have?
                Endo International has 223,100,000 shares outstanding.
                  What happened to Endo International’s price movement after its last earnings report?
                  Endo International reported an EPS of $0.66 in its last earnings report, beating expectations of $0.441. Following the earnings report the stock price went down -29.703%.
                    Which hedge fund is a major shareholder of Endo International?
                    Among the largest hedge funds holding Endo International’s share is Paulson & Co Inc. It holds Endo International’s shares valued at 40M.


                      Endo International Stock Analysis

                      Smart Score
                      Price Target
                      ▲(262.80% Upside)
                      Moderate Sell
                      The Endo International stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      Endo International

                      Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. The firm operates through the following segments: U.S. Branded-Specialty & Established Pharmaceuticals, U.S. Branded-Sterile Injectables, U.S. Generic Pharmaceuticals and International Pharmaceuticals. The U.S. Branded-Specialty & Established Pharmaceuticals segment offers prescription products to treat and manage conditions in urology, urologic oncology, endocrinology, pain and orthopedics. The U.S. Branded-Sterile Injectables segment consists primarily of branded sterile injectable products such as VASOSTRICT, ADRENALIN and APLISOL, among others, and certain generic sterile injectable products, including ertapenem for injection and ephedrine sulfate injection, among others. The U.S. Generic Pharmaceuticals segment consists of a differentiated product portfolio including solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmics and sprays and includes products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health and cardiovascular disease markets, among others. The International Pharmaceuticals segment includes a variety of pharmaceutical products for the Canadian, Latin American, South African, and world markets. The company was founded in 1997 and is headquartered Dublin, Ireland.

                      Similar Stocks
                      Price & Change
                      Bausch Health Companies
                      Perrigo Company
                      Horizon Therapeutics

                      Popular Stocks

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis